Relmada Therapeutics has announced the acquisition of Sepranolone, a Phase 2b ready neurosteroid developed for treating Tourette syndrome (TS) and related compulsive disorders, from Asarina Pharma AB ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results